Buscar
Mostrando ítems 1-8 de 8
Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores
(Wiley, 2016-03-01)
[Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF).
AIM: The aim of this study is to assess concordance ...
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
(Elsevier, 2017-09-19)
[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
(Elsevier, 2020-04-14)
[Abstract]
Background: While many risk factors for Atrial Fibrillation (AF) have been identified, there are important differences in their relative impact between sexes. The aim of our study was to investigate the influence ...
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
(NLM, 2019-12-24)
[Abstract]
Background.
Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ...
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
(Wiley, 2020-10-16)
[Abstract] Background: Atrial fibrillation (AF) and peripheral artery disease (PAD) are common conditions that increase cardiovascular risk. We determined the association between PAD and prognosis in a cohort of real-world ...
Quality of anticoagulation with vitamin K antagonists
(Wiley, 2015-05-11)
[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
(SAGE, 2015-07-30)
[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...